AcroMeta gain a LOA for USD 6.1mln design and build works

Mr Lim Say Chin, Executive Chairman AcroMeta

AcroMeta Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has received a letter of award (“LOA”) for the design and build of laboratory and office space worth approximately S USD6.1 million from a global clinical research organisation that helps companies conduct clinical development of drugs or medical devices (the “Project”).

The Project site work is commencing soon and a binding contract would be executed in due course. In the unlikely event that the execution of contract is not followed through, the Group is safeguarded as it would be entitled to claim a maximum value of approximately S USD 1.8 million for value of works performed.

Said Mr Lim Say Chin, Executive Chairman, “We are greatly encouraged that the Project involves a new customer in the biotechnology space. This speaks of the confidence that our customers have in our capabilities. We will continue to work hard towards delivering quality services, leveraging on our established track record and proven expertise as controlled environment specialist engineers.”

The Project is expected to contribute positively to the earnings per share and net tangible assets per share of the Group for the current financial year ending 30 September 2023.

To the best of the Directors’ knowledge, none of the Directors and controlling shareholders of the Company have any interests, direct or indirect, in the Project, other than through their respective shareholdings in the Company.

Press release received on mail

Related articles to biotechnology sector:

ArisGlobal acquires Amplexor Life Sciences

IntoCell signs MTA with ADC Therapeutics

RELATED ARTICLES

Recent News